Abstract:Manufacturing and characterizing hydroxycamptothecin inclusion liposomes, establishing their quality standard and testing their in vitro anti-tumor activity is of significance for potential application. The neutralization agitation method was used to prepare hydroxycamptothecin inclusion and film evaporation method was utilized to manufacture hydroxycamptothecin inclusion liposomes. The phase solubility method, differential scanning calorimetry and infrared spectroscopy were used to identify the prepared inclusion complex. The hydroxycamptothecin inclusion liposomes were characterized for particle morphology, size, in vitro release and stability. The hepatoma (HepG-2), lung cancer (A549), and gastric cancer (SGC-7901) cell lines were used as models for preliminary evaluation of anti-cancer effect from the hydroxycamptothecin inclusion liposonnes, done by MTT colorimetry, cytometer experiments, and apoptosis staining. The anti-cancer evaluation was compared with commercially available hydroxycamptothecin. The results showed the hydroxycamptothecin inclusion was successfully prepared by neutralization agitation method. Phase solubility method, differential scanning calorimetry and infrared spectroscopy proved the formation of the hydroxycamptothecin inclusion. The hydroxycamptothecin inclusion liposomes were successfully prepared by film evaporation method. (2) The inclusions were found to be spherical, with average particle size of 119.7 nm, zeta potential of -45.6 mV, average inclusion rate of 70.55%, and drug-loading was 14.60%. The inclusions were also found to have a sustained release effect, when compared to the commercially available hydroxyccamptothecine. The hydroxyccamptothecine inclusion liposonnes had better stability at 4 degrees. (3) The hydroxycamptothecin inclusion liposomes also exhibited better inhibition effect for the three kinds of cancer cell lines above, when compared to the commercially available hydroxycamptothecin the anti-cancer effect being at a dose-dependent manner. Neutralization agitation and thin film evaporation methods can be used to manufacture hydroxycamptothecin inclusion liposomes with better encapsulation efficiency, drug-loading content, stability, sustained-release effect and stronger anti-cancer activity.

Studies on the hydroxypropyl-β-cyclodextrin inclusion complexes of 10-hydroxycamptothecin

Protection of cyclodextrin on the structure of lactone form of 10-hydroxycamptothecin

Preparation of inclusion complex of daidzein and hydropropyl-β- cyclodextrin

Investigation of the Improved Effects of 2-Hydroxypropyl-β-cyclodextrin on Solubility, Dissolution Rate, and Intestinal Absorptive Profile of Tanshinone IIA in Rats

Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-O-(2-Hydroxypropyl)-β-Cyclodextrin: A Joint Experimental and Theoretical Study

Complexation of Tanshinone IIA with 2-Hydroxypropyl-β-cyclodextrin: Effect on Aqueous Solubility, Dissolution Rate, and Intestinal Absorption Behavior in Rats

[The Study on the Preparation and Spectroscopic Properties of Hydroxypropyl-Beta-cyclodextrin/glipizide Inclusion Complex].

Complex of 9-nitro-camptothecin in hydroxypropyl-β-cyclodextrin: In vitro and in vivo evaluation

Liposomes Encapsulating 10-Hydroxycamptothecin-Cyclodextrin Complexes and Their In Vitro Anti-Tumor Activities.

The Study of Water-Soluble Lycopene Inclusion Product

Study on the inclusion compound of qucertin with hydroxypropyl-beta-cyclodextrin]

Preparation and Characterization of Hydroxypropyl-β-cyclodextrin/Glibenclamide Inclusion Complex

Study on the Solubilization of 2-Hydroxypropyl-β-cyclodextrin for Carvedilol

Study on the physico-chemical properties of hydroxycamptothecin-phospholipid complex

Physicochemical properties and mechanism of solubilised neohesperidin system based on inclusion complex of hydroxypropyl-beta-cyclodextrin

Inclusion Complex of Tamibarotene with Hydroxypropyl-Β-cyclodextrin: Preparation, Characterization, In-Vitro and In-Vivo Evaluation

Preparation and Properties of Puerarin-Hydroxypropyl-β-cyclodextrin Inclusion Compound

Studies on Econazole Nitrate Hydroxypropyl-Β-cyclodextrin Inclusion Complex

Inclusion Action of Hydroxypropyl-Β-cyclodextrin with Five Flavones

Solubilization of Hydropropyl-Β-cyclodextrin to Paclitaxel and Its Relative Molecular Inclusion Mechanism

Preparation of Inclusion Complex of Apigenin-Hydroxypropyl-β-cyclodextrin by Using Supercritical Antisolvent Process for Dissolution and Bioavailability Enhancement